Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

Abstract Introduction The incidence of herpes zoster (HZ) rises steeply after the age of 50 years and the number of HZ cases and complications such as postherpetic neuralgia (PHN) is predicted to increase because of the ageing population. The objective of this study was to estimate the cost-effectiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Makoto Shiragami (Author), Akiko Mizukami (Author), Toshihiko Kaise (Author), Desmond Curran (Author), Desiree Van Oorschot (Author), Benjamin Bracke (Author), Daisuke Watanabe (Author)
Format: Book
Published: Adis, Springer Healthcare, 2019-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items